BioCardia, Inc.
BCDA
$0.84
-$0.04-5.03%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -7.78M | -8.23M | -8.54M | -8.79M | -8.39M |
| Total Depreciation and Amortization | 15.00K | 24.00K | 36.00K | 48.00K | 60.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 878.00K | 935.00K | 1.06M | 1.15M | 1.21M |
| Change in Net Operating Assets | -595.00K | -167.00K | 74.00K | -712.00K | -856.00K |
| Cash from Operations | -7.48M | -7.44M | -7.37M | -8.31M | -7.97M |
| Capital Expenditure | -10.00K | -7.00K | -2.00K | -4.00K | -6.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -10.00K | -7.00K | -2.00K | -4.00K | -6.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 8.71M | 8.70M | 8.73M | 9.14M | 9.30M |
| Repurchase of Common Stock | -197.00K | -197.00K | -140.00K | -140.00K | -140.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -1.02M | -930.00K | -858.00K | -1.13M | -1.18M |
| Cash from Financing | 7.49M | 7.57M | 7.73M | 7.87M | 7.98M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 2.00K | 125.00K | 357.00K | -441.00K | 0.00 |